UF Joins Global Study Into Parkinson’s Onset and Progression
The University of Florida has been selected to join The Michael J. Fox Foundation’s landmark clinical study, the Parkinson’s Progression Markers Initiative (PPMI), a global project seeking to discover new insights into the onset and progression of Parkinson’s disease by studying people with and without the disease.
“The Norman Fixel Institute for Neurological Diseases at UF Health is excited to join this initiative,” said Nikolaus McFarland, M.D., Ph.D., a UF professor of neurology and principal investigator of UF’s study site. “We hope that these insights will help improve diagnostic tests and spur the development of novel treatments to slow progression and eventually prevent Parkinson’s.”
Learn more about UF Joins Global Study Into Parkinson’s Onset and Progression.